<DOC>
	<DOCNO>NCT00712322</DOCNO>
	<brief_summary>This study evaluate pharmacodynamics pharmacokinetics darifenacin liquid oral suspension child , age 2-15 year , neurogenic detrusor overactivity . The result support benefit-risk base dosage recommendation phase IIIa clinical trial .</brief_summary>
	<brief_title>2 Week Open-label Pharmacodynamic Pharmacokinetic Study Multiple Doses Darifenacin Liquid Oral Suspension Children ( 2 - 15 Yrs ) With Neurogenic Detrusor Overactivity</brief_title>
	<detailed_description />
	<mesh_term>Darifenacin</mesh_term>
	<criteria>Male female patient age 215 year Documented detrusor overactivity associate known neurological condition meningomyelocele spinal cord injury , confirm urodynamics baseline Using clean intermittent catheterization ( CIC ) regular basis Participating bowel program regular basis Able swallow study medication accordance protocol Patients and/or parent/guardian able complete bladder diary follow study procedure Treatment drug know significantly affect urinary bladder urinary bladder outlet function Fecal impaction . Patients may include , condition resolve Clinically significant anatomical abnormality acquire disorder urinary tract Previous reconstructive surgery ( augmentation etc . ) bladder bladder outlet Symptomatic urinary tract infection unresolved time urodynamic study and/or completion bladder diary . Diabetes insipidus Electro stimulation therapy bladder training within 2 week prior Visit 1 time study Concomitant disease , use darifenacin contraindicate History hypersensitivity darifenacin drug similar chemical structure Patients physical cognitive impairment condition opinion investigator make patient unsuitable inclusion Female adolescent childbearing potential , unless use acceptable method contraception Pregnant nursing ( lactate ) female adolescents Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Pediatric , Children , Urodynamics , Oral Suspension , Overactive bladder , Dose-finding , Neurogenic Detrusor Overactivity , Meningomyelocele , Spinal cord injury</keyword>
</DOC>